[Federal Register Volume 63, Number 165 (Wednesday, August 26, 1998)]
[Proposed Rules]
[Page 45427]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-22813]
[[Page 45427]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 101
[Docket No. 98N-0044]
RIN 0910-AA59
Regulations on Statements Made for Dietary Supplements Concerning
the Effect of the Product on the Structure or Function of the Body;
Extension of Comment Period
AGENCY: Food and Drug Administration, HHS.
ACTION: Proposed rule; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is extending to
September 28, 1998, the comment period for the proposed rule that
appeared in the Federal Register of April 29, 1998 (63 FR 23624). The
document proposed regulations defining the types of statements that can
be made concerning the effect of a dietary supplement on the structure
or function of the body. Interested persons were given until August 27,
1998, to comment on the proposed rule. This action is being taken in
response to requests for an extension of the comment period.
DATES: Written comments by September 28, 1998.
ADDRESSES: Submit written comments to the Dockets Management Branch
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Jeanne Latham, Center for Food Safety
and Applied Nutrition (HFS-456), Food and Drug Administration, 200 C
St. SW., Washington, DC 20204, 202-205-4697.
SUPPLEMENTARY INFORMATION: In the Federal Register of April 29, 1998
(63 FR 23624), FDA issued a proposed rule defining the types of
statements that can be made concerning the effect of a dietary
supplement on the structure or function of the body.
Interested persons were given until August 27, 1998, to comment on
the proposal. FDA has received several requests for an extension of the
comment period. After evaluating these requests, the agency has decided
to extend the comment period on the proposed rule until September 28,
1998.
To be considered, written comments regarding the proposed rule must
be received by September 28, 1998, by the Dockets Management Branch
(address above). Two copies of any comments are to be submitted, except
that individuals may submit one copy. Comments are to be identified
with Docket No. 98N-0044. Received comments may be seen in the Dockets
Management Branch between 9 a.m. and 4 p.m., Monday through Friday.
Dated: August 20, 1998.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 98-22813 Filed 8-25-98; 8:45 am]
BILLING CODE 4160-01-F
